...
首页> 外文期刊>American Journal of Obstetrics and Gynecology >Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study
【24h】

Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study

机译:终身癌症风险和组合口服避孕药:皇家普通科学家口语避孕研究

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Oral contraceptives have been used by hundreds of millions of women around the world. Important questions remain regarding the very long-term cancer risks that are associated with oral contraception. Despite previous research, important questions remain about the safety of these contraceptives: (1) How long do endometrial, ovarian, and colorectal cancer benefits persist? (2) Does combined oral contraceptive use during the reproductive years produce new cancer risks later in life? (3) What is the overall balance of cancer among past users as they enter the later stages of their lives?
机译:背景:口服避孕药已经被世界各地数亿妇女使用。 仍然存在与口头避孕有关的长期癌症风险的重要问题。 尽管先前的研究,重要的问题仍然是关于这些避孕药的安全性的:(1)子宫内膜,卵巢和结直肠癌的效果需要多长时间? (2)组合口服避孕药在生殖多年期间产生新的癌症风险,以后生命后? (3)过去用户之间的癌症整体平衡是什么,因为他们进入他们生活的后期阶段?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号